Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 1-9

  Lou, Miao ^a   Zhang, Li na ^b   Ji, Pei gang ^a   Feng, Fu qiang ^a   Liu, Jing hui ^a   Yang, Chen ^a   Li, Bao fu ^a   Wang, Liang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Autophagy; Neuroglioma; Quercetin nanoparticle

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P53; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG EFFECTS; GLIOMA; METABOLISM; NUDE MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; AUTOPHAGY; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; QUERCETIN; SIGNAL TRANSDUCTION; TUMOR BURDEN;

EID: 84986538316     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.08.055     Document Type: Article

References (44)

1. [1] Walker, C., Baborie, A., Crooks, D., Wilkins, S., Jenkinson, M.D., Biology, genetics and imaging of glial cell tumours. Br. J. Radiol. 84 (2011), 90–106.
2. [2] Shakur, S.F., Bit-Ivan, E., Watkin, W.G., Merrell, R.T., Farhat, H.I., Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literature. Case Rep. Med., 2013, 2013, 132679.
3. [3] Parson, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008), 1807–1812.
4. [4] Anjaneyulu, M., Chopra, K., Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Phys. 31 (2004), 244–248.
5. [5] Liao, Y.R., Lin, J.Y., Quercetin intraperitoneal administration ameliorates lipopolysaccharide-induced systemic inflammation in mice. Life Sci. 137 (2015), 89–97.
6. [6] Chiow, K.H., Phoon, M.C., Putti, T., Tan, B.K., Chow, V.T., Evaluation of antiviral activities of houttuynia cordata thunb extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 9 (2016), 1–7.
7. [7] Guazelli, C.F., Fattori, V., Colombo, B.B., Georgetti, S.R., Vicentini, F.T., Casagrande, R., Baracat, M.M., Verri, W.A. Jr., Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms. J. Nat. Prod. 76 (2013), 200–208.
8. [8] Boesch-Saadatmandi, C., Loboda, A., Wagner, A.E., Stachurska, A., Jozkowicz, A., Dulak, J., Doring, F., Wolffram, S., Rimbach, G., Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 22 (2011), 293–299.
9. [9] Tang, Y., Gao, C., Xing, M., Li, Y., Zhu, L., Wang, D., Yang, X., Liu, L., Yao, P., Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage. Food Chem. Toxicol. 50 (2012), 1194–1200.
10. [10] Chen, B.L., Wang, L.T., Huang, K.H., Wang, C.C., Chiang, C.K., Liu, S.H., Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway. J. Nutr. Biochem. 25 (2014), 1226–1234.
11. [11] Kim, H., Moon, J.Y., Ahn, K.S., Cho, S.K., Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxid. Med. Cell. Longev., 2013, 2013, 596496.
12. [12] Wang, S., Zhou, Y., Tan, J., Xu, J., Yang, J., Liu, Y., Computational modeling of magnetic nanoparticle targeting to stent surface under high gradient field. Comput. Mech. 53 (2014), 403–412.
13. [13] Puhl, A.C., Fagundes, M., dos Santos, K.C., Polikarpov, I., das Gracas, M.F., da Silva, F., Fernandes, J.B., Vieira, P.C., Forim, M.R., Preparation and characterization of polymeric nanoparticles loaded with the flavonoid luteolin, by using factorial design. Int. J. Drug Deliv. 3 (2011), 683–698.
14. [14] Leonor Pinzon-Daza, M., Campia, I., Kopecka, J., Garzon, R., Ghigo, D., Rigant, C., Nanoparticle-and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. Curr. Drug Metab. 14 (2013), 625–640.
15. [15] Hosta-Rigau, L., Schattling, P., Teo, B.M., Lynge, M.E., Städler, B., Recent progress of liposomes in nanomedicine. J. Mater. Chem. B 2 (2014), 6686–6691.
16. [16] Wang, W., Wang, C., Ding, X.Q., Pan, Y., Gu, T.T., Wang, M.X., Liu, Y.L., Wang, F.M., Wang, S.J., Kong, L.D., Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipidaccumulation in diabetic rats. Br. J. Pharmacol. 169 (2013), 1352–1371.
17. [17] Sinha, S., Levine, B., The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27:Suppl. 1 (2008), S137–S148.
18. [18] Guichet, P.O., Guelfi, S., Ripoll, C., Teigell, M., Sabourin, J.C., Bauchet, L., Rigau, V., Rothhut, B., Hugnot, J.P., Asymmetric distribution of GFAP in glioma multipotent cells. PLoS One, 11, 2016, e0151274.
19. [19] Kim, Y.C., Guan, K.L., mTOR: a pharmacologic target for autophagy regulation. J. Clin. Investig. 125 (2015), 25–32.
20. [20] Lim, H.J., Crowe, P., Yang, J.L., Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J. Cancer Res. Clin. Oncol. 141 (2015), 671–689.
21. [21] Song, B.Q., Chi, Y., Li, X., Du, W.J., Han, Z.B., Tian, J.J., Li, J.J., Chen, F., Wu, H.H., Han, L.X., et al. Inhibition of notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K/AKT/mTOR pathway. Cell. Physiol. Biochem. 36 (2015), 1991–2002.
22. [22] Carneiro, B.A., Kaplan, J.B., Altman, J.K., Giles, F.J., Platanias, L.C., Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. Cancer Biol. Ther. 16 (2015), 648–656.
23. [23] Cagnol, S., Chambard, J.C., ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence. FEBS J. 277 (2010), 2–21.
24. [24] Ogier-Denis, E., Pattingre, S., El Benna, J., Codogno, P., Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J. Biol. Chem. 275 (2000), 39090–39095.
25. [25] Martin, P., Poggi, M.C., Chambard, J.C., Boulukos, K.E., Pognonec, P., Low dose cadmium poisoning results in sustained ERK phosphorylation and caspase activation. Biochem. Biophys. Res. Commun. 350 (2006), 803–807.
26. [26] Bhattacharya, S., Pal, K., Sharma, A.K., Dutta, S.K., Lau, J.S., Yan, I.K., Wang, E., Elkhanany, A., Alkharfy, K.M., Sanyal, A., Patel, T.C., Chari, S.T., Spaller, M.R., Mukhopadhyay, D., GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PLoS One, 9, 2014, e114409.
27. [27] Zhou, Y.F., Wang, Q.X., Zhou, H.Y., Chen, G., Autophagy activation prevents sevoflurane-induced neurotoxicity in H4 human neuroglioma cells. Acta Pharmacol. Sin. 37 (2016), 580–588.
28. [28] Tsao, R., Chemistry and biochemistry of dietary polyphenols. Nutrients 2 (2010), 1231–1246.
29. [29] Dong, Y.S., Wang, J.L., Feng, D.Y., Qin, H.Z., Wen, H., Yin, Z.M., Gao, G.D., Li, C., Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int. J. Med. Sci. 11 (2014), 282–290.
30. [30] Kobori, M., Takahashi, Y., Sakurai, M., Akimoto, Y., Tsushida, T., Oike, H., Ippoushi, K., Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol. Nutr. Food Res. 60 (2016), 300–312.
31. [31] Leonor Pinzon-Daza, M., Campia, I., Kopecka, J., Garzon, R., Ghigo, D., Rigant, C., Nanoparticle-and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. Curr. Drug Metab. 14 (2013), 625–640.
32. [32] Iyer, A.K., Khaled, G., Fang, J., Maeda, H., Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11 (2006), 812–818.
33. [33] Cho, H.J., Yoon, H.Y., Koo, H., Ko, S.H., Shim, J.S., Lee, J.H., Kim, K., Chan, K.I., Kim, D.D., Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic for tumor-targeted delivery of docetaxel. Biomaterials 32 (2011), 7181–7190.
34. [34] Kim, Y.C., Guan, K.L., mTOR: a pharmacologic target for autophagy regulation. J. Clin. Investig. 125 (2015), 25–32.
35. [35] Ciarcia, R., Damiano, S., Montagnaro, S., Pagnini, U., Ruocco, A., Caparrotti, G., d'Angelo, D., Boffo, S., Morales, F., Rizzolio, F., et al. Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells. Cell Cycle 12 (2013), 2839–2848.
36. [36] Booth, L.A., Tavallai, S., Hamed, H.A., Cruickshanks, N., Dent, P., The role of cell signalling in the crosstalk between autophagy and apoptosis. Cell. Signal. 26 (2013), 549–555.
37. [37] Tanida, I., Autophagosome formation and molecular mechanism of autophagy. Antioxid. Redox Signal. 14 (2010), 2201–2214.
38. [38] Jiang, H., Cheng, D., Liu, W., Peng, J., Feng, J., Protein kinase C inhibits autophagy and phosphorylates LC3. Biochem. Biophys. Res. Commun. 395 (2010), 471–476.
39. [39] Viiri, J., Amadio, M., Marchesi, N., Hyttinen, J.M., Kivinen, N., Sironen, R., et al. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS One, 8, 2013, e69563.
40. [40] Huang, J., Manning, B.D., A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem. Soc. Trans. 37 (2009), 217–222.
41. [41] Cagnol, S., Van Obberghen-Schilling, E., Chambard, J.C., Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11 (2006), 337–346.
42. [42] Vaux, D.L., Apoptogenic factors released from mitochondria. Biochim. Biophys. Acta 1813 (2011), 546–550.
43. [43] Cory, S., Adams, J.M., The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 (2002), 647–656.
44. [44] Cheng, Y., Qiu, F., Tashiro, S., Onodera, S., Ikejima, T., ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem. Biophys. Res. Commun. 376 (2008), 483–488.